Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT04140500
Title	Dose Escalation Study of a PD1-LAG3 Bispecific Antibody in Patients With Advanced and/or Metastatic Solid Tumors
Recruitment	Active, not recruiting
Gender	both
Phase	Phase I
Variant Requirements	Yes
Sponsors	Hoffmann-La Roche
Indications	melanoma esophagus squamous cell carcinoma lung non-small cell carcinoma Advanced Solid Tumor
Therapies	RO7247669
Age Groups:	adult \| senior
Covered Countries	TUR \| ISR \| GBR \| ESP \| DNK